Pure Global AI
ANVISA registration 10287411790Valid until May 04, 2036

IMMUNOHISTOCHEMISTRY - CARCINOMA MARKERS IN GENERAL

ANVISA Registration Number: 10287411790ROCHE DIAGNÓSTICA BRASIL LTDACELL MARQUE CORPORATIONRisk Class III
Verified
Device names
Technical name
IMMUNOHISTOCHEMISTRY - CARCINOMA MARKERS IN GENERAL
View exact technical-name matches →
PT: IMUNOHISTOQUÍMICA - MARCADORES DE CARCINOMAS EM GERAL
Commercial name
Família Marcadores de Carcinoma Geral - CM III
View exact commercial-name matches →
Risk class
Class III
Registration details
Registration Number
10287411790
Process Number
25351017926202622
CNPJ
30280358000186
Company information
Registration Holder
ROCHE DIAGNÓSTICA BRASIL LTDA
Manufacturer
CELL MARQUE CORPORATION
Manufacturing Country
United States
PT: ESTADOS UNIDOS DA AMÉRICA
Dates and status
Publication Date
May 04, 2026
Validity
04/05/2036
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for IMMUNOHISTOCHEMISTRY - CARCINOMA MARKERS IN GENERAL in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10287411790 and manufactured by CELL MARQUE CORPORATION. The registration is held by ROCHE DIAGNÓSTICA BRASIL LTDA with validity until May 04, 2036.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.